摘要
目的:对血液透析仪在急性肾衰竭治疗中的临床应用效果展开分析与探讨。方法:选取天津市中西医结合医院南开医院2019年6月~2021年6月收治的118例急性肾衰竭患者,随机分为对照组和观察组,各59例;给予对照组常规肾内科治疗,观察组则采用透析仪实施血液净化治疗,比较两组患者的治疗效果、肾功能和并发生发生率。结果:经治疗,观察组的治疗总有效率为94.92%,优于对照组的81.36%(P<0.05);观察组的MAP、Scr、Bun和K+分别为(67.3±6.7)mmHg、(340.9±45.5)μmol/L、(11.8±4.3)mol/L和(3.9±1.1)mmol/L,均低于对照组的(81.5±8.2)mmHg、(461.4±73.2)μmol/L、(18.5±8.1)mol/L和(4.8±1.3)mmol/L(P<0.05),观察组的并发症发生率低于对照组(P>0.05)。结论:在急性肾衰竭患者治疗中运用血液透析仪,能够显著提升患者的治疗效果,且并发症发生率较低。
Objective:To study the clinical effect of hemodialysis in the treatment of acute renal failure.Methods:118 patients with acute renal failure treated in Tianjin Hospital of ITCWM Nankai Hospital from June 2019 to June 2021 were selected.They were randomly divided into control group and observation group,with 59 cases in each group;The control group was given routine renal medicine treatment,and the observation group was given blood purification treatment by dialysis instrument.The therapeutic effect,renal function and incidence of complications were compared between the two groups.Results:After treatment,the total effective rate of the observation group was 94.92%,which was better than 81.36%of the control group(P<0.05);MAP,Scr,Bun and K+in the observation group were(67.3±6.7)mmHg,(340.9±45.5)μmol/L,(11.8±4.3)mol/L and(3.9±1.1)mmol/L,which were lower than(81.5±8.2)mmHg,(461.4±73.2)μmol/L,(18.5±8.1)mol/L and(4.8±1.3)mmol/L in the control group(P<0.05);The incidence of complications in the observation group was lower than that in control group(P>0.05).Conclusion:The use of hemodialysis in the treatment of patients with acute renal failure can significantly improve the treatment effect of patients,and the incidence of complications is low.
作者
付伟
FU Wei(Department of Penetration,Tianjin Hospital of ITCWM Nankai Hospital,Tianjin 300100)
出处
《中国医疗器械信息》
2023年第10期81-83,共3页
China Medical Device Information
关键词
血液透析仪
急性肾衰竭
血肌酐
尿素氮
hemodialysis instrument
acute renal failure
serum creatinine
urea nitrogen
